Found: 37
Select item for more details and to access through your institution.
Cover Image, Volume 23, Issue 8.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 8, p. 1, doi. 10.1111/dom.14493
- By:
- Publication type:
- Article
A real‐world study of user characteristics, safety and efficacy of open‐source closed‐loop systems and Medtronic 670G.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 8, p. 1989, doi. 10.1111/dom.14439
- By:
- Publication type:
- Article
Decreasing prevalence of retinopathy in childhood‐onset type 1 diabetes over the last decade: A comparison of two cohorts diagnosed 10 years apart.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 8, p. 1950, doi. 10.1111/dom.14438
- By:
- Publication type:
- Article
Real‐world performance of the MiniMed™ 670G system in Europe.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 8, p. 1942, doi. 10.1111/dom.14424
- By:
- Publication type:
- Article
A randomized controlled trial of transition from insulin pump to multiple daily injections using insulin degludec.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 8, p. 1936, doi. 10.1111/dom.14423
- By:
- Publication type:
- Article
Short‐term intensive insulin as induction and maintenance therapy for the preservation of beta‐cell function in early type 2 diabetes (RESET‐IT Main): A 2‐year randomized controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 8, p. 1926, doi. 10.1111/dom.14421
- By:
- Publication type:
- Article
Long‐term incidence of hypoglycaemia‐related events after bariatric surgery or usual care in the Swedish Obese Subjects study: A register‐based analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 8, p. 1917, doi. 10.1111/dom.14420
- By:
- Publication type:
- Article
Combined application of genetic and polygenic risk scores for type 1 diabetes risk prediction.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 8, p. 2001, doi. 10.1111/dom.14419
- By:
- Publication type:
- Article
Technology in the management of type 2 diabetes: Present status and future prospects.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 8, p. 1722, doi. 10.1111/dom.14418
- By:
- Publication type:
- Article
Association of lactation with maternal risk of type 2 diabetes: A systematic review and meta‐analysis of observational studies.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 8, p. 1902, doi. 10.1111/dom.14417
- By:
- Publication type:
- Article
Patient‐reported outcomes in adults with type 1 diabetes in global real‐world clinical practice: The SAGE study.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 8, p. 1892, doi. 10.1111/dom.14416
- By:
- Publication type:
- Article
Effect of empagliflozin on cardiorenal outcomes and mortality according to body mass index: A subgroup analysis of the EMPA‐REG OUTCOME trial with a focus on Asia.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 8, p. 1886, doi. 10.1111/dom.14415
- By:
- Publication type:
- Article
Efficacy of metformin monotherapy in US veterans with type 2 diabetes and preexisting chronic kidney disease stage 3.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 8, p. 1879, doi. 10.1111/dom.14414
- By:
- Publication type:
- Article
Distribution patterns of intramyocellular and extramyocellular fat by magnetic resonance imaging in subjects with diabetes, prediabetes and normoglycaemic controls.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 8, p. 1868, doi. 10.1111/dom.14413
- By:
- Publication type:
- Article
Pharmacokinetics, safety, tolerability and efficacy of cotadutide, a glucagon‐like peptide‐1 and glucagon receptor dual agonist, in phase 1 and 2 trials in overweight or obese participants of Asian descent with or without type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 8, p. 1859, doi. 10.1111/dom.14412
- By:
- Publication type:
- Article
Renal haemodynamic response to sodium‐glucose cotransporter‐2 inhibition does not depend on protein intake: An analysis of three randomized controlled trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 8, p. 1961, doi. 10.1111/dom.14411
- By:
- Publication type:
- Article
Effect of exenatide twice daily and dapagliflozin, alone and in combination, on markers of kidney function in obese patients with type 2 diabetes: A prespecified secondary analysis of a randomized controlled clinical trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 8, p. 1851, doi. 10.1111/dom.14410
- By:
- Publication type:
- Article
Intensive management of obesity in people with severe chronic kidney disease: A review.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 8, p. 1733, doi. 10.1111/dom.14409
- By:
- Publication type:
- Article
Ambulatory noninsulin treatment of type 2 diabetes mellitus in the United States, 2015 to 2019.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 8, p. 1843, doi. 10.1111/dom.14408
- By:
- Publication type:
- Article
Urinary dipeptidyl peptidase‐4 protein is increased by linagliptin and is a potential predictive marker of urine albumin‐to‐creatinine ratio reduction in patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 8, p. 1968, doi. 10.1111/dom.14407
- By:
- Publication type:
- Article
Insulin glargine 300 units/mL for the treatment of individuals with type 2 diabetes in the real world: A review of the DELIVER programme.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 8, p. 1713, doi. 10.1111/dom.14405
- By:
- Publication type:
- Article
Acute ketosis inhibits appetite and decreases plasma concentrations of acyl ghrelin in healthy young men.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 8, p. 1834, doi. 10.1111/dom.14402
- By:
- Publication type:
- Article
Prevalence and progression of chronic kidney disease among patients with type 2 diabetes: Insights from the DISCOVER study.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 8, p. 1956, doi. 10.1111/dom.14401
- By:
- Publication type:
- Article
Associations between second‐line glucose‐lowering combination therapies with metformin and HbA1c, body weight, quality of life, hypoglycaemic events and glucose‐lowering treatment intensification: The DISCOVER study.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 8, p. 1823, doi. 10.1111/dom.14400
- By:
- Publication type:
- Article
Longevity of the novel ConvaTec infusion set with Lantern technology.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 8, p. 1973, doi. 10.1111/dom.14395
- By:
- Publication type:
- Article
Parent and patient knowledge of nasal glucagon use and efficacy in a large cohort of Italian children and adolescents with type 1 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 8, p. 2004, doi. 10.1111/dom.14398
- By:
- Publication type:
- Article
Duration of type 2 diabetes does not appear to moderate hypoglycaemia rate with insulin degludec versus insulin glargine U100.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 8, p. 1983, doi. 10.1111/dom.14397
- By:
- Publication type:
- Article
Day‐to‐day variability of insulin requirements in the inpatient setting: Observations during fully closed‐loop insulin delivery.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 8, p. 1978, doi. 10.1111/dom.14396
- By:
- Publication type:
- Article
Glucagon‐like peptide‐1 receptor agonists improve biomarkers of inflammation and oxidative stress: A systematic review and meta‐analysis of randomised controlled trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 8, p. 1806, doi. 10.1111/dom.14399
- By:
- Publication type:
- Article
Improved postprandial glucose metabolism in type 2 diabetes by the dual glucagon‐like peptide‐1/glucagon receptor agonist SAR425899 in comparison with liraglutide.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 8, p. 1795, doi. 10.1111/dom.14394
- By:
- Publication type:
- Article
Preinfection glycaemic control and disease severity among patients with type 2 diabetes and COVID‐19: A retrospective, cohort study.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 8, p. 1995, doi. 10.1111/dom.14393
- By:
- Publication type:
- Article
Efficacy and safety of LY2963016 insulin glargine versus insulin glargine (Lantus) in Chinese adults with type 2 diabetes: A phase III, randomized, open‐label, controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 8, p. 1786, doi. 10.1111/dom.14392
- By:
- Publication type:
- Article
Diabetes, Obesity and Metabolism.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 8, p. 1711, doi. 10.1111/dom.13782
- Publication type:
- Article
Sex differences in risk factors for cognitive decline and dementia, including death as a competing risk, in individuals with diabetes: Results from the ADVANCE trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 8, p. 1775, doi. 10.1111/dom.14391
- By:
- Publication type:
- Article
The beneficial short‐term effects of a high‐protein/low‐carbohydrate diet on glycaemic control assessed by continuous glucose monitoring in patients with type 1 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 8, p. 1765, doi. 10.1111/dom.14390
- By:
- Publication type:
- Article
Henagliflozin as add‐on therapy to metformin in patients with type 2 diabetes inadequately controlled with metformin: A multicentre, randomized, double‐blind, placebo‐controlled, phase 3 trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 8, p. 1754, doi. 10.1111/dom.14389
- By:
- Publication type:
- Article
Prediabetes and the risk of heart failure: A meta‐analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 8, p. 1746, doi. 10.1111/dom.14388
- By:
- Publication type:
- Article